Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. DENTE (PISA, Italy), G. Lenzini (PISA, Italy), G. Parri (PISA, Italy), M. Micol (PISA, Italy), S. Cianchetti (PISA, Italy), G. De Cusatis (PISA, Italy), L. Carrozzi (PISA, Italy). Asthmatic Traits in a Group of non-cystic fibrosis Bronchiectasis. 2368

Member's Comments

No comment yet.

Related content which might interest you: Exacerbations in non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Impact of Anemia On Clinically Stable Adult Non-cystic Fibrosis Bronchiectasis Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Characteristic of a subgroup of non cystic fibrosis bronchiectasis with concomitant asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Bronchiectasis Source: Respipedia Article Year: 2017 Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Assessment of aerobic fitness in cystic fibrosis and asthmatic children Source: International Congress 2014 – Respiratory function at rest and during exercise Year: 2014 Relationship between Neutrophilic Airway Inflammation and Airway Colonisation in non-Cystic Fibrosis Bronchiectasis Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Adaptation of prevotella during acute infectious pulmonary exacerbation Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Small-airway dysfunction among non-cystic bronchiectasis patients with different Bronchiectasis Severity Index Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 IPF - Idiopathic Pulmonary Fibrosis Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152 Year: 2019 The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Lung MRI findings in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Screening colonoscopy in adults with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018